# Arts Way Manufacturing Co Inc: financial statements, quarterly

ARTW · Nasdaq · CIK 7623 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/artw.md) · [Financials](/companies/artw/financials.md) · [Filings](/companies/artw/filings.md) · [Insiders](/companies/artw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/artw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,852 d](/filings/0001437749-25-004172.md) | [5,723](/filings/0001437749-25-011614.md) | [6,730](/filings/0001437749-25-022639.md) | [5,876](/filings/0001437749-25-030917.md) | [6,170 d](/filings/0001437749-26-003904.md) | [5,141](/filings/0001437749-26-012161.md) | [6,337](/filings/0001437749-26-023597.md) | [6,432](/filings/0001437749-26-032521.md) | [5,065 d](/filings/0001437749-26-003904.md) | [6,640](/filings/0001437749-26-012161.md) | [7,854](/filings/0001437749-26-023597.md) | [5,615](/filings/0001437749-26-032521.md) |
| Cost of revenue | $k | [4,939 d](/filings/0001437749-25-004172.md) | [4,250](/filings/0001437749-25-011614.md) | [4,824](/filings/0001437749-25-022639.md) | [4,176](/filings/0001437749-25-030917.md) | [3,941 d](/filings/0001437749-26-003904.md) | [3,644](/filings/0001437749-26-012161.md) | [4,277](/filings/0001437749-26-023597.md) | [4,666](/filings/0001437749-26-032521.md) | [4,121 d](/filings/0001437749-26-003904.md) | [4,729](/filings/0001437749-26-012161.md) | [5,822](/filings/0001437749-26-023597.md) | [3,955](/filings/0001437749-26-032521.md) |
| Gross profit | $k | [1,913 d](/filings/0001437749-25-004172.md) | [1,474](/filings/0001437749-25-011614.md) | [1,907](/filings/0001437749-25-022639.md) | [1,700](/filings/0001437749-25-030917.md) | [2,229 d](/filings/0001437749-26-003904.md) | [1,497](/filings/0001437749-26-012161.md) | [2,060](/filings/0001437749-26-023597.md) | [1,766](/filings/0001437749-26-032521.md) | [944 d](/filings/0001437749-26-003904.md) | [1,911](/filings/0001437749-26-012161.md) | [2,032](/filings/0001437749-26-023597.md) | [1,660](/filings/0001437749-26-032521.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [86.6 d](/filings/0001437749-25-004172.md) | [(380)](/filings/0001437749-25-011614.md) | [169](/filings/0001437749-25-022639.md) | [154](/filings/0001437749-25-030917.md) | [518 d](/filings/0001437749-26-003904.md) | [2.5](/filings/0001437749-26-012161.md) | [511](/filings/0001437749-26-023597.md) | [345](/filings/0001437749-26-032521.md) | [(568) d](/filings/0001437749-26-003904.md) | [330](/filings/0001437749-26-012161.md) | [287](/filings/0001437749-26-023597.md) | [(70.0)](/filings/0001437749-26-032521.md) |
| Interest expense | $k | [170 d](/filings/0001437749-24-005855.md) | [166](/filings/0001437749-24-011724.md) | [160](/filings/0001437749-25-022639.md) | [150](/filings/0001437749-25-030917.md) | [128 d](/filings/0001437749-26-003904.md) | [75.7](/filings/0001437749-26-012161.md) | [99.7](/filings/0001437749-26-023597.md) | [83.7](/filings/0001437749-26-032521.md) | [108 d](/filings/0001437749-26-003904.md) | [111](/filings/0001437749-26-012161.md) | [113](/filings/0001437749-26-023597.md) | [114](/filings/0001437749-26-032521.md) |
| Income tax | $k | [80.9 d](/filings/0001437749-25-004172.md) | [(113)](/filings/0001437749-25-011614.md) | [(0.6)](/filings/0001437749-25-022639.md) | [(2.7)](/filings/0001437749-25-030917.md) | [75.1 d](/filings/0001437749-26-003904.md) | [(14.7)](/filings/0001437749-26-012161.md) | [394](/filings/0001437749-26-023597.md) | [67.1](/filings/0001437749-26-032521.md) | [(44.1) d](/filings/0001437749-26-003904.md) | [59.0](/filings/0001437749-26-012161.md) | [52.4](/filings/0001437749-26-023597.md) | [(40.3)](/filings/0001437749-26-032521.md) |
| Net income | $k | [(308) d](/filings/0001437749-25-004172.md) | [(465)](/filings/0001437749-25-011614.md) | [(33.3)](/filings/0001437749-25-022639.md) | [(26.2)](/filings/0001437749-25-030917.md) | [832 d](/filings/0001437749-26-003904.md) | [(55.8)](/filings/0001437749-26-012161.md) | [1,482](/filings/0001437749-26-023597.md) | [254](/filings/0001437749-26-032521.md) | [(646) d](/filings/0001437749-26-003904.md) | [196](/filings/0001437749-26-012161.md) | [173](/filings/0001437749-26-023597.md) | [(140)](/filings/0001437749-26-032521.md) |
| Diluted EPS | $ per share | not reported | [(0.09)](/filings/0001437749-25-011614.md) | [(0.01)](/filings/0001437749-25-022639.md) | [(0.01)](/filings/0001437749-25-030917.md) | not reported | [(0.01)](/filings/0001437749-26-012161.md) | [0.29](/filings/0001437749-25-022639.md) | [0.05](/filings/0001437749-26-032521.md) | not reported | [0.04](/filings/0001437749-26-012161.md) | not reported | [(0.03)](/filings/0001437749-26-032521.md) |
| Basic EPS | $ per share | not reported | [(0.09)](/filings/0001437749-25-011614.md) | [(0.01)](/filings/0001437749-25-022639.md) | [(0.01)](/filings/0001437749-25-030917.md) | not reported | [(0.01)](/filings/0001437749-26-012161.md) | [0.29](/filings/0001437749-26-023597.md) | [0.05](/filings/0001437749-26-032521.md) | not reported | [0.04](/filings/0001437749-26-012161.md) | [0.03](/filings/0001437749-26-023597.md) | [(0.03)](/filings/0001437749-26-032521.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001437749-25-004172.md) | [0.0](/filings/0001437749-24-011724.md) | [0.0](/filings/0001437749-24-022557.md) | [0.0](/filings/0001437749-24-031031.md) | [0.0](/filings/0001437749-26-003904.md) | [0.0](/filings/0001437749-25-011614.md) | [0.0](/filings/0001437749-25-022639.md) | [0.0](/filings/0001437749-25-030917.md) | [0.0](/filings/0001437749-26-032521.md) | [0.0](/filings/0001437749-26-012161.md) | [0.0](/filings/0001437749-26-023597.md) | [0.0](/filings/0001437749-26-032521.md) |
| Current assets | $m | [15.1](/filings/0001437749-25-004172.md) | [14.7](/filings/0001437749-24-011724.md) | [13.6](/filings/0001437749-24-022557.md) | [14.0](/filings/0001437749-24-031031.md) | [13.1](/filings/0001437749-26-003904.md) | [13.0](/filings/0001437749-25-011614.md) | [13.3](/filings/0001437749-25-022639.md) | [14.2](/filings/0001437749-25-030917.md) | [14.8](/filings/0001437749-26-032521.md) | [17.0](/filings/0001437749-26-012161.md) | [16.0](/filings/0001437749-26-023597.md) | [17.3](/filings/0001437749-26-032521.md) |
| Total assets | $m | [24.4](/filings/0001437749-25-004172.md) | [24.3](/filings/0001437749-24-011724.md) | [23.2](/filings/0001437749-24-022557.md) | [23.5](/filings/0001437749-24-031031.md) | [21.2](/filings/0001437749-26-003904.md) | [21.0](/filings/0001437749-25-011614.md) | [20.9](/filings/0001437749-25-022639.md) | [21.8](/filings/0001437749-25-030917.md) | [22.5](/filings/0001437749-26-032521.md) | [24.6](/filings/0001437749-26-012161.md) | [23.7](/filings/0001437749-26-023597.md) | [26.2](/filings/0001437749-26-032521.md) |
| Current liabilities | $m | [9.4](/filings/0001437749-25-004172.md) | [9.7](/filings/0001437749-24-011724.md) | [8.7](/filings/0001437749-24-022557.md) | [9.1](/filings/0001437749-24-031031.md) | [6.6](/filings/0001437749-26-003904.md) | [6.5](/filings/0001437749-25-011614.md) | [4.9](/filings/0001437749-25-022639.md) | [5.6](/filings/0001437749-25-030917.md) | [6.4](/filings/0001437749-26-032521.md) | [8.4](/filings/0001437749-26-012161.md) | [7.4](/filings/0001437749-26-023597.md) | [10.1](/filings/0001437749-26-032521.md) |
| Total liabilities | $m | [12.8](/filings/0001437749-25-004172.md) | [13.0](/filings/0001437749-24-011724.md) | [11.9](/filings/0001437749-24-022557.md) | [12.2](/filings/0001437749-24-031031.md) | [9.1](/filings/0001437749-26-003904.md) | [8.9](/filings/0001437749-25-011614.md) | [7.3](/filings/0001437749-25-022639.md) | [7.9](/filings/0001437749-25-030917.md) | [9.2](/filings/0001437749-26-032521.md) | [11.0](/filings/0001437749-26-012161.md) | [9.9](/filings/0001437749-26-023597.md) | [12.5](/filings/0001437749-26-032521.md) |
| Long-term debt | $m | [2.6](/filings/0001437749-25-004172.md) | [2.0](/filings/0001437749-25-011614.md) | [2.6](/filings/0001437749-24-022557.md) | [2.5](/filings/0001437749-24-031031.md) | [2.0](/filings/0001437749-26-003904.md) | [2.3](/filings/0001437749-26-012161.md) | [2.3](/filings/0001437749-26-023597.md) | [1.9](/filings/0001437749-25-030917.md) | [2.3](/filings/0001437749-26-032521.md) | [2.3](/filings/0001437749-26-012161.md) | [2.2](/filings/0001437749-26-023597.md) | [2.2](/filings/0001437749-26-032521.md) |
| Current portion of debt | $m | [0.1](/filings/0001437749-25-004172.md) | [0.1](/filings/0001437749-25-011614.md) | [0.1](/filings/0001437749-24-022557.md) | [0.1](/filings/0001437749-24-031031.md) | [0.1](/filings/0001437749-26-003904.md) | [0.2](/filings/0001437749-26-012161.md) | [0.2](/filings/0001437749-26-023597.md) | [0.1](/filings/0001437749-25-030917.md) | [0.2](/filings/0001437749-26-032521.md) | [0.2](/filings/0001437749-26-012161.md) | [0.2](/filings/0001437749-26-023597.md) | [0.2](/filings/0001437749-26-032521.md) |
| Shareholders' equity | $m | [11.6](/filings/0001437749-26-003904.md) | [11.2](/filings/0001437749-25-011614.md) | [11.2](/filings/0001437749-25-022639.md) | [11.3](/filings/0001437749-25-030917.md) | [12.1](/filings/0001437749-26-032521.md) | [12.1](/filings/0001437749-26-012161.md) | [13.6](/filings/0001437749-26-023597.md) | [13.9](/filings/0001437749-26-032521.md) | [13.3](/filings/0001437749-26-032521.md) | [13.5](/filings/0001437749-26-012161.md) | [13.8](/filings/0001437749-26-023597.md) | [13.7](/filings/0001437749-26-032521.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [463 d](/filings/0001437749-25-004172.md) | [(99.3)](/filings/0001437749-25-011614.md) | [1,247 d](/filings/0001437749-25-022639.md) | [282 d](/filings/0001437749-25-030917.md) | [1,197 d](/filings/0001437749-26-003904.md) | [(102)](/filings/0001437749-26-012161.md) | [1,354 d](/filings/0001437749-26-023597.md) | [(1,267) d](/filings/0001437749-26-032521.md) | [(889) d](/filings/0001437749-26-003904.md) | [148](/filings/0001437749-26-012161.md) | [362 d](/filings/0001437749-26-023597.md) | [1,338 d](/filings/0001437749-26-032521.md) |
| Capital expenditure | $k | [272 d](/filings/0001437749-25-004172.md) | [281](/filings/0001437749-25-011614.md) | [231 d](/filings/0001437749-25-022639.md) | [102 d](/filings/0001437749-25-030917.md) | [110 d](/filings/0001437749-26-003904.md) | [82.7](/filings/0001437749-26-012161.md) | [131 d](/filings/0001437749-26-023597.md) | [261 d](/filings/0001437749-26-032521.md) | [153 d](/filings/0001437749-26-003904.md) | [176](/filings/0001437749-26-012161.md) | [341 d](/filings/0001437749-26-023597.md) | [1,325 d](/filings/0001437749-26-032521.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [4.5 d](/filings/0001437749-25-004172.md) | [37.7](/filings/0001437749-25-011614.md) | [0.0 d](/filings/0001437749-25-022639.md) | [0.0 d](/filings/0001437749-25-030917.md) | [0.0 d](/filings/0001437749-26-003904.md) | [1.5](/filings/0001437749-26-012161.md) | [0.0 d](/filings/0001437749-26-023597.md) | [0.0 d](/filings/0001437749-26-032521.md) | [0.0 d](/filings/0001437749-26-003904.md) | [0.0](/filings/0001437749-26-012161.md) | [1.7 d](/filings/0001437749-26-023597.md) | [0.0 d](/filings/0001437749-26-032521.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-05-31) | Q3 FY2022 (2022-08-31) | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,629](/filings/0001437749-23-019854.md) | [4,700](/filings/0001437749-23-028228.md) | [4,977](/filings/0001437749-24-011724.md) | [5,014](/filings/0001437749-24-022557.md) | [5,009](/filings/0001437749-24-031031.md) | [5,023](/filings/0001437749-25-011614.md) | [5,068](/filings/0001437749-25-022639.md) | [5,072](/filings/0001437749-25-030917.md) | [5,055](/filings/0001437749-26-012161.md) | [5,094](/filings/0001437749-25-022639.md) | [5,106](/filings/0001437749-25-030917.md) | [5,140](/filings/0001437749-26-012161.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,206,386 at 2026-10-02, from the cover of the [10-Q filed 2026-10-13](/filings/0001437749-26-032521.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.